Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000204195 | SCV000261879 | likely benign | Chuvash polycythemia; Von Hippel-Lindau syndrome | 2024-01-18 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000412359 | SCV000488996 | likely benign | Von Hippel-Lindau syndrome | 2016-08-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000575638 | SCV000675795 | likely benign | Hereditary cancer-predisposing syndrome | 2016-01-13 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001711983 | SCV001941456 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001711983 | SCV002821158 | likely benign | not provided | 2024-03-01 | criteria provided, single submitter | clinical testing | VHL: BP4, BP7 |
KCCC/NGS Laboratory, |
RCV000412359 | SCV004016215 | likely benign | Von Hippel-Lindau syndrome | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003977572 | SCV004799028 | likely benign | VHL-related disorder | 2019-05-29 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
All of Us Research Program, |
RCV000412359 | SCV004824042 | likely benign | Von Hippel-Lindau syndrome | 2023-12-18 | criteria provided, single submitter | clinical testing |